Catalyst Wire Dossier Catalyst Wire Dossier

Egalet-002

· Egalet Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Egalet-002, covering 2018-03-05 to 2018-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain [Phase 3]

See pricing